We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Mediwatch | MDW | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.875 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.875 | 5.875 |
| Top Posts |
|---|
Posted at 23/12/2013 14:34 by troutisout hulk2004,As in everything shareholders tend to overhype the situation, certainly the early MDW days did that. However PSAwatch as a product although good was never going to take off in this country. MDW was too small to take it internationally in any real way. In the end MDW was spread too wide and too thinly, it really did need more behind it. Unfortunately they were unable to get any real backing and therefore could just continue as they were and bring the new products into reality and hope that a certain company offered to acquire them. Laborie have been sniffing around MDW's market for quite a long time now and the BoD were well aware of this. They have been very good at adding things to the shopfront window and making sure the window was dressed as well as possible. Sometimes this is ignored, although some have aired their grievances the BoD have managed to get us a large premium to the share price over the last 2 years. Yes it may leave some out of pocket, but a lot less than they were back in September at 2.25p bid. Anyway, it is now coming to a close and people will soon have cash, instead of MDW paper and that in itself is a start. Good luck everyone. Trout. |
Posted at 11/12/2013 21:54 by dorset64 Trout, my point about being right was that I stated it was the wrong business model for MDW to be releasing experienced sales staff, in favour of taking on university graduates. You argued against me on that but in your latest posts, you then go on to state that the cost cutting (graduates instead of sales staff etc.) was unsustainable move & MDW would fail if they carried on.That to me tells me that you now agree with my previous posts and they were correct. One other point I don't really understand, and perhaps I'm being a little thick here but why are Lab paying in excess of £10m for MDW, when they have also now bought MDW's suppliers which, in turn they could had simply turned off the supply tap to MDW. If they had done this then MDW, along with it's share price would have drowned as with no supply, they would not be able to carry on with their business until a new supplier had been found. So the question is, are there other suppliers out there that could have supplied MDW and, if so how long would the authorities/approval |
Posted at 10/12/2013 16:18 by troutisout Banjo,If there were then they would have surely come forward? Especially if MDW is undervalued. Audax are paying £8.5m plus debts of £1.8m and expecting costs of between £1.5m and £1.7m for their offer for MDW, that is up to £12m. On a forecast £300k ptp? That is a big premium. There are very few companies in the urodynamic area, Laborie are the biggest, none of the big medical co's want to be in this area that is why MDT sold it to MDW for £1.7m (and that got reduced!). Any company interested would have made a move by now, no-one has come forward. A rejection of the offer would lead to large fall in the SP, the main holders want to get out and are not prepared to put more finance in, Mediwatch would not be able to raise funds and with Laborie's new trump card, the acquisition of T-Doc, who would put money into Mediwatch? With the predator owning the supplier of catheters for our equipment and no real alternative apart form going back to the old technology, who would want to use Mediwatch equipment, who is going to buy a new Mediwatch platform if they can't use the T-Doc air charged catheters? So sales will fall, costs need to go up, exceptional costs from the offer of £300k, a debt of £1.8m which will need servicing and unsupportive instis and main holders (they know the consequences they will not hang around they will get out with what they can get) and finally a Board of Directors that also wanted an exit and I am sure won't suddenly favour running the Company again. So I really don't see an alternative, to just say surely someone else must want MDW is naïve, we have been valued at £3.5m for the last couple of years and no-one else has come forward, the offer period was the time that another predator would come forward, they haven't. PSAwatch has been very slow to roll out, it is certainly not yet in a position where it can offer the company a lifeline, in fact after any rejection of the offer, the sale of PSAwatch would probably be the only way to raise funds for the Company to continue. DYOR, You made light of my 'assumptions', I have spoken with two institutional holders and 4 other 1%+ holders, as well as many other large holders (0.5%+). All of them are happy to take the offer and move on, in fact a couple already have sold into the market. It may not be the offer they hoped for and they may not be happy with the price but they have enough info to know there is no alternative and therefore they want out. It is still far better than the 2p-2.25p that the share has been bid for so long. Trout. |
Posted at 03/12/2013 14:09 by troutisout Banjo, I hate to say this but the time for optimistic thoughts was six months ago, not now.I don't see another bid coming in, there was only one other possible suitor I could see, however for them to really be able to counter offer they would have needed to come forward as soon as MDW announced the approach. I am not sure who you think might come forward, but CR Bard have been reducing their urological side, the other big medicals haven't come close to urodynamics so can't see them coming forward and why would anyone buy MDW for PSAwatch when they could probably get it for much less from Laborie, if Laborie wanted to sell. You don't think I haven't been enquiring and speaking with people on this? There seems very little belief there will be a counter bid now. The chances of a counter bid are also reduced by the workings of this deal which Audax have managed to sew up tightly. I cannot believe that people are now valuing MDW higher than £10.5m, when just over two months ago it was valued at a third of that and people weren't bothered with the undervaluation then. Audax since their initial approach to MDW have tied up the acquisition of T-Doc, they aren't going to raise the offer now, so it is really time to bite the bullet and move on. I certainly welcome the chance to get my capital out of this illiquid and unsupported share and invest elsewhere, where was all this optimism and positivity over the last couple of years??? Why are the posters that have spent the last couple of years bemoaning the Company now positive? Because the only way they can get their wish and see it fail is to get the offer rejected and watch MDW struggle on. They know that will happen and they can then continue to tell us how bad our investment is. 6p was never going to suit everyone, but 6p is 6p more than nothing, it is 3.5p more than the share price has been sitting at most of this year and it is being offered in cash and shortly. Even if the offer doesn't go through for some reason or another, how will Mediwatch survive? How will it service it's debt, pay off the costs of the approach, how can it fight against Laborie? It has two products in R&D which have great potential but need far more funding, where will this come from? A rejection of the offer, with the facts at hand, is like Turkeys voting for Christmas....... |
Posted at 03/12/2013 11:05 by dorset64 Hulk brought up a good point also in that when the deal went through for Lab to buy MDW's suppliers, they would had fully been aware of the implications this would of had on MDW, and their existing/future customers. They would had known that it will strangle MDW into losing existing customers, losing new customers and leave them waiting years for their own supply demand to be met by themselves or others. With Lab being such astute business men and if as has been said there is no merit in MDW after the suppliers had been bought, then why did they not simply wait, say 6-12 months and come back then and buy MDW for probably less than £2m or less? With no immediate supply alternatives MDW would had likely gone to the wall but no, they have paid £8m plus the debt, plus £3m + expenses to PS, plus £m? to the other BoD's right now instead of coming back in under a year with circa 10% of the cost? The more that is revealed the more of a stitch up this appears. |
Posted at 02/12/2013 12:18 by troutisout p1nkfish, I sometimes struggle to understand your view, for months now you have been posting doom and gloom at 2.5p and then now we have an offer for 6p you are hyper enthusiastic for more.You like to show you do your research although some of your views were a little off piste shall we see, do you remember the bed and SIPP fiasco? Philip Stimpson as you can now see from the documents lives in the Caribbean and as such is a tax exile - Dorset hasn't quite cottoned on to that also. Anyway that is in the past, some questions for you and if you look into them you will be able to find far more answers than you are presently trying to conjure up. 1. What percentage of MDW revenue comes from Urodynamics? 2. What percentage of that comes from consumables? 3. Who do most of the Urodynamic Companies source a lot of their catheters from? 4. What is Audax's stated aim and raison d'etre for acquiring Laborie? 5. What remarks have been made about the Lifetech acquisition and particularly the amount paid? 6. Philip Stimpson was employed by MDW on about £165k p.a. and some pension contributions. 7. the new service agreement gives him £320k pa for 3 years. 8. What is the difference between the two? (clue, I am not looking at the difference in the amount) 9. I haven't the foggiest how many trips PS has done this year but know he has attended 12 board meetings in the UK and has also visited many, many countries this year, think about this with the above. 10. Now read the scheme document, really closely and hopefully some things will stand out. 11. I recently found where one of the MDW loans came from whilst doing a google search, have a look at the scheme document to see more, the terms and the nature of the lender. Also look at the debt figure that Audax is likely to pick up on top of the purchase price. 12. Everyone seems to be thinking that MDW have the better hand here, wake up and smell the roses, Laborie is backed by a multibillion fund that specialises in backing a market leader and then consolidating that market, think carefully about how they can do this? |
Posted at 21/11/2013 13:19 by troutisout Dorset, I do not agree with you, quite simply because they got rid of one sales manager in the UK and employed one or two graduates, who apparently did very well, I don't agree because these were UK based jobs. I am talking about the worldwide face of MDW, who was doing most of the work with new customers, new distributors and new Urologists. Who was doing a lot of the demonstrations and training people to use the equipment? You came on here many years ago now, just because of the HAWK debacle and me being one who disagreed with you. You have slated MDW and over the period have recommended several other investments, first was AGQ, then TAIH, then TPL, then silver and some gold and silver miners. I stuck with boring MDW and although we had many people telling us that MDW was a dead duck and going to fail, I bought whenever I could and researched hard. After a while I stopped posting a lot of my research here as it just led to arguments and disrupted the thread. When I have posted here, I have tried to be fair, as I would be attacked for 'ramping' if I ever said anything positive. In the meantime I have been in email contact with many of the posters here and have discussed with them in more detail, any research, we all have! The reason for that was purely because the disruptive nature of this BB meant no-one could see the posts of note and it became apparent that many posters had stopped reading (I did on occasion ask for posters to post a hello to see who was still there, but no response meant no point in posting on the BB). So in the end you probably did come over and wreck my MDW thread (like you said you would) well done! However it would seem that you wrecked other's opportunities to discuss and find out more about MDW and eventually MDW due to this takeover has proved a far better investment than any of your tips in the corresponding period. So not sure what you have contributed here really, apart from to show how someone who purports to be a successful businessman can turn into a BB troll. Let's face it I had reason to post here, you have posted for nearly 3 years for what? A couple of grand investment that you bought two years in? Really, would any normal person spend so much time on a BB where they had so little financial interest? |
Posted at 19/11/2013 11:32 by dorset64 Can someone clarify for me as I may just be being simple here.Question, once the deal with Lab goes through are they planning to take MDW private & off the market, or is the plan to keep MDW listed, plough money into it and to keep the two co's separate? For those selling out now & if kept listed, would it not therefore be a good time to hold and to see if your shares will gain over the coming years with the backing of a 'large corp' in the industry with respect to monetary terms? The 'scheme', what exactly is the scheme and for them to use the tax offsets available to MDW, surely they would have to keep MDW running but to 'adjust' their profits into MDW for it to be effective and, if so and with MDW hitting profits, then the share price should go up along with the profits. |
Posted at 03/11/2013 10:10 by daniel I have been an investor in MDW since 2003, I have supported the company through fundings and endured dilutions over the years. I want a decent return for my supports and commitment to the directors. I feel it is ridiculous for anyone in my position to anticipate an offer of 6-8p at this stage of the company's development, as that is far less than most long-termer's average outlay in the company - People expecting (6-8p) must keep it to themselves. Nothing less than 20p, should be acceptable to any serious investor in MDW. PSA watch alone, will be worth more than that in a few years. If Labories is interested in acquiring MDW, it should pay a great and fair premium for it; since the current price is screwed up. Otherwise, the directors must walk away from the deal. There are not many companies with the same potential reward as MDW out there; and if you sell it for a token, there is little to do with the money, than to stick it in a bank account. I am tired of seeing people who labour for many years in research, funding and developing a great company; only to sell out for peanuts, and then realise their folly a few year down the line. It is even more abhorrent to see some cases of; BOD's betrayers, brokerage spiving and even government fiascos which are the greatest anomaly of UK plc in our time, and the greatest pajaro of impoverish of the people of this great country. In my opinion, 20p is the beginning of a fair price to sell MDW to any willing predator, otherwise I am willing to wait a couple of years. I wish the management God's guidance and continued success in their endeavours. |
Posted at 20/10/2013 09:56 by greedfear What offer price to expect?I have done a little research and this is what I've found with regards to valuation of medical devices companies: 1. medical devices companies have recently been sold for enterprises values that were 3.5 x sales. For MDW (using trailing 12 months sales)that would make 3.5 x 9.92 is 34.7. Taking the net debt and cash of MDW into account that would make a marketcap of 33.2 or 23p per share; 2. medical devices companies have recently been sold for 12.8 x ebitda. For MDW that would imply; 12.8 x 0.54 = 6.9 => 5p per share; 3. nasdaq medical devices index is currently 24.3 x p/e. For MDW: 24.3 x 0.17 is 4.1 => 3p 4. nasdaq medical devices index is currently 3.4 x book value. For MDW: 3.4 x 6.09 = 20.7 => 15p What the offer price could be? well, take your pick anywhere between 3-23p. :) The calculations do show though that there's a lot of room for an increase in the share price and that's all I care about for the time being. Even if a take over will not take place I'm pretty sure the share price of MDW will remain at a far higher level than 3p. Frankly with all that's currently happening with the company I would rather see a take over at a later time (unless they would offer 23p per share offcourse :) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
